Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Treximet and Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache.

NCT01916395 is registered in ClinicalTrials.gov with Gary E. Ruoff, M.D. as lead sponsor.

NCT NCT01916395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01916395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Treximet and Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache.
Lead sponsor
Gary E. Ruoff, M.D.
Phase
Observational
Overall status
Completed
Start date
December 31, 2009
Completion date
July 31, 2011
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine